TNFRSF14 and urinary bladder carcinoma: In bladder cancer, the signature consisting of 7 immune‐related lncRNAs, including TNFRSF14‐AS1, was clarified to be a prognostic marker, whereas the TNFRSF14‐AS1 was considered as a protective effector.27